Carbonyl and oxidative stress in patients with breast cancer--is there a relation to the stage of the disease?

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neoplasma (Bratislava)

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 17447853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Free radicals, metals and antioxidants in oxidative stress-induced cancer.

  2006cited by this paper
• Soluble receptor for advanced glycation end products in patients with decreased renal function.

  2006cited by this paper
• Proliferative stimulus of lung fibroblasts on lung cancer cells is impaired by the receptor for advanced glycation end-products.

  2006cited by this paper
• Life and Death Decisions: Ceramide Generation and EGF Receptor Trafficking Are Modulated by Oxidative Stress

  2005cited by this paper
• Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development

  2005cited by this paper
• Advanced Glycation End Products in Human Cancer Tissues: Detection of Nε‐(Carboxymethyl)lysine and Argpyrimidine

  2005cited by this paper
• Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes, and cancer.

  2005cited by this paper
• Understanding RAGE, the receptor for advanced glycation end products

  2005cited by this paper
• Nuclear proteasome activation and degradation of carboxymethylated histones in human keratinocytes following glyoxal treatment.

  2005cited by this paper
• Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma.

  2004cited by this paper
• Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells.

  2004cited by this paper
• Oxidative DNA damage and disease: induction, repair and significance.

  2004cited by this paper
• Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer.

  2003cited by this paper
• Differential effects between amphoterin and advanced glycation end products on colon cancer cells

  2003cited by this paper
• Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays.

  2003cited by this paper
• Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells.

  2003cited by this paper
• Expression of receptors for advanced glycation end‐products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer

  2002cited by this paper
• RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease

  2002cited by this paper
• RAGE expression and AGE-induced MAP kinase activation in Caco-2 cells.

  2001cited by this paper
• The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.

  2001cited by this paper
• Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds.

  1999cited by this paper
• Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications.

  1999cited by this paper
• Determination of Advanced Glycation End Products in Serum by Fluorescence Spectroscopy and Competitive ELISA

  1997cited by this paper
• Differential messenger RNA and protein expression of the receptor for advanced glycosylated end products in normal lung and non-small cell lung carcinoma.

  1997cited by this paper
• Advanced oxidation protein products as a novel marker of oxidative stress in uremia.

  1996cited by this paper

• Redox Balance in Cancer in the Context of Tumor Prevention and Treatment

  2025cites this paper
• Reopening Pandora's box: is there a role for HDL in breast cancer?

  2025cites this paper
• Dietary advanced glycation end‐products (dAGEs) are not associated with the risk of cancer incidence. A systematic review and meta‐analysis of prospective cohort studies

  2024cites this paper
• The evaluation of oxidative stress parameters in breast and colon cancer

  2021cites this paper
• Dietary Antioxidant Capacity Promotes a Protective Effect against Exacerbated Oxidative Stress in Women Undergoing Adjuvant Treatment for Breast Cancer in a Prospective Study

  2021cites this paper
• Dietary Advanced Glycation End-Products and Mortality after Breast Cancer in the Women's Health Initiative

  2021cites this paper
• T Cell Epitope Prediction and Its Application to Immunotherapy

  2021cites this paper
• The Involvement of the Oxidative Stress Status in Cancer Pathology: A Double View on the Role of the Antioxidants

  2021cites this paper
• Dietary Advanced Glycation End-products (AGE) and Risk of Breast Cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO)

  2020cites this paper
• Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health‐AARP Diet and Health Study

  2020cites this paper
• Glyoxalase 1 expression analysis by immunohistochemistry in breast cancer.

  2020cites this paper
• Diet Quality Is Associated with Serum Antioxidant Capacity in Women with Breast Cancer: A Cross Sectional Study

  2020cites this paper
• Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma

  2019cites this paper
• Postoperative patient-controlled epidural or intravenous pain treatment after one-stage unilateral hybrid atrial fibrillation ablation surgery?

  2019cites this paper
• Oxidative stress in relation to obesity in breast cancer.

  2019cites this paper
• Urinary Advanced Oxidation Protein Product: A Potential Oxidative Damage Marker for Cancer

  2018cites this paper
• The influence of glyoxalase 1 gene polymorphism on its expression at different stages of breast cancer in Egyptian women

  2017cites this paper
• Benzocoumarin Hydrazine: A Large Stokes Shift Fluorogenic Sensor for Detecting Carbonyls in Isolated Biomolecules and in Live Cells.

  2017cites this paper
• Exacerbation of colon carcinogenesis by Blastocystis sp.

  2017cites this paper
• Detecting Blood-Based Biomarkers in Metastatic Breast Cancer: A Systematic Review of Their Current Status and Clinical Utility

  2017cites this paper
• Modification of cysteine 457 in plakoglobin modulates the proliferation and migration of colorectal cancer cells by altering binding to E-cadherin/catenins

  2017cites this paper
• Circulating Advanced Oxidation Protein Products as Oxidative Stress Biomarkers and Progression Mediators in Pathological Conditions Related to Inflammation and Immune Dysregulation.

  2016cites this paper
• Verbal social support for newly diagnosed breast cancer patients during surgical decision-making visits

  2016cites this paper
• The Characteristics and Roles of Advanced Oxidation Protein Products in Atherosclerosis

  2016cites this paper
• Accumulation of the advanced glycation end product carboxymethyl lysine in breast cancer is positively associated with estrogen receptor expression and unfavorable prognosis in estrogen receptor-negative cases

  2016cites this paper
• HMGB1, S100 proteins and other RAGE ligands in cancer - markers, mediators and putative therapeutic targets.

  2016cites this paper
• Lack of the association between single nucleotide polymorphism (L55M) in PON1 gene and susceptibility With Breast Cancer in Markazi Province

  2016cites this paper
• [The advanced oxidation protein products as potential diagnostic and prognostic factor in diseases of the indicated participation of oxidative stress].

  2014cites this paper
• Assessment of ischemia-modified albumin levels in patients with rheumatoid arthritis.

  2014cites this paper
• PON I and GLO I Gene Polymorphisms and Their Association with Breast Cancer: A Case-Control Study in a Population from Southern Italy

  2014cites this paper
• EGF and TNF-a levels and oxidative/ nitrosative stress in breast and non-small cell lung cancer patients

  2013cites this paper
• Distribution of Selenium and Oxidative Stress in Breast Tumor-Bearing Mice

  2013cites this paper
• Thioredoxin-mediated redox regulation of resistance to endocrine therapy in breast cancer.

  2013cites this paper
• Preclinical evaluation of the novel monoclonal antibody H6-11 for prostate cancer imaging.

  2013cites this paper
• Oxidative stress status in metastatic breast cancer patients receiving palliative chemotherapy and its impact on survival rates

  2012cites this paper
• Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients

  2012cites this paper
• 4-hydroxy estradiol-induced oxidant-mediated signaling is involved in the development of breast cancer

  2011cites this paper
• Prognostic Potential and Tumor Growth-Inhibiting Effect of Plasma Advanced Glycation End Products in Non-Small Cell Lung Carcinoma

  2011cites this paper
• Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance

  2011cites this paper
• Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer.

  2011cites this paper
• Does Chemotherapy-Induced Oxidative Stress Improve the Survival Rates of Breast Cancer Patients?

  2011cites this paper
• Glyoxalase I Ala111Glu gene polymorphism: No association with breast cancer risk but correlated with absence of progesterone receptor

  2010cites this paper
• Protein Oxidation in Breast Microenvironment: Nipple Aspirate Fluid Collected from Breast Cancer Women Contains Increased Protein Carbonyl Concentration

  2009influential citation
• Glyoxalase I Glu111Ala Polymorphism in Patients with Breast Cancer

  2009cites this paper
• CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study

  2009influential citation
• Protein Modifications as Potential Biomarkers in Breast Cancer

  2009cites this paper
• Enhanced formation of advanced oxidation protein products in IBD

  2008cites this paper
• Impact of antioxidant supplementation on chemotherapeutic toxicity: A systematic review of the evidence from randomized controlled trials

  2008cites this paper
• Evaluation of oxidative stress in colorectal cancer patients.

  2008cites this paper
• No Evidence for Advanced Glycation Endproducts in Cancer

  2007cites this paper
• Reply

  2007cites this paper